Titelia

Holdings of ORBIMED ADVISORS LLC

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
93 in 5 countries
Top ten
46.4 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Edgewise Therapeutics Inc 15,518,492488.8M $
2Enliven Therapeutics Inc 7,959,538312M $
3Eli Lilly & Co 236,800217.8M $
4Boston Scientific Corp 2,382,100149.5M $
5Sionna Therapeutics Inc 3,530,702141.5M $
6MBX Biosciences Inc 3,637,887108.6M $
7Corvus Pharmaceuticals Inc 7,165,006104.8M $
8Argenx SE 136,900100M $
9Edwards Lifesciences Corp 1,230,60098.5M $
10Intuitive Surgical Inc 208,70096.2M $
11Compass Therapeutics Inc 15,219,99480.5M $
12Merck & Co Inc 663,40079.8M $
13Structure Therapeutics Inc 1,475,40371.1M $
14ArriVent Biopharma Inc 3,027,32869.8M $
15Disc Medicine Inc 1,067,55068.3M $
16ARS Pharmaceuticals Inc 8,288,51066.6M $
17CG oncology Inc 948,26764.2M $
18Stryker Corp 182,50060M $
19Bristol-Myers Squibb Co 925,00056.1M $
20Mineralys Therapeutics Inc 2,052,90055.6M $
21Praxis Precision Medicines Inc 172,50055.6M $
22Pfizer Inc 1,946,50054.7M $
23Dyne Therapeutics Inc 2,917,88452.9M $
24Natera Inc 262,00052.4M $
25Abivax SA 465,70051.9M $
26Upstream Bio Inc 5,693,58951.2M $
27Danaher Corp 265,80050.4M $
28Caris Life Sciences Inc 2,806,81150.2M $
29Ascendis Pharma A/S 181,97741.6M $
30Shattuck Labs Inc 6,306,12740.5M $
31Guardant Health Inc 435,20040.2M $
32Alnylam Pharmaceuticals Inc 119,00039.4M $
33Prelude Therapeutics Inc 10,909,25637.3M $
34Crinetics Pharmaceuticals Inc 999,00036.3M $
35Axsome Therapeutics Inc 213,92136.2M $
36ORIC Pharmaceuticals Inc 2,693,92934.1M $
37Elevance Health Inc 114,70033.6M $
38Relmada Therapeutics Inc 4,715,86432.8M $
39Forte Biosciences Inc 1,196,95531M $
40Trevi Therapeutics Inc 2,454,40029.3M $
41Esperion Therapeutics Inc 10,570,30029M $
42NeuroPace Inc 2,096,52727.6M $
43Rhythm Pharmaceuticals Inc 314,10027.3M $
44Thermo Fisher Scientific Inc 46,50022.9M $
45Syndax Pharmaceuticals Inc 962,30022.5M $
46BrightSpring Health Services Inc 497,80021.2M $
47Lexeo Therapeutics Inc 3,602,45020.7M $
48Sutro Biopharma Inc 801,14420M $
49Nektar Therapeutics 275,00019.8M $
50Krystal Biotech Inc 69,10017.8M $
51Palvella Therapeutics Inc 134,60016.8M $
52Corbus Pharmaceuticals Holdings Inc 1,737,28716.3M $
53Vera Therapeutics Inc 369,59614.9M $
54Q32 Bio Inc 2,252,98714.5M $
55Aadi Bioscience Inc 4,166,00014.4M $
56Amgen Inc 39,90014M $
57Alignment Healthcare Inc 791,00013.9M $
58EyePoint Inc 1,069,14713.8M $
59Janux Therapeutics Inc 983,60013.7M $
60BioCryst Pharmaceuticals Inc 1,425,20013.6M $
61Bicara Therapeutics Inc 667,30013.3M $
62BioAge Labs Inc 711,81112.4M $
63Cogent Biosciences Inc 322,10012.4M $
64Alumis Inc 548,16312.1M $
65Regeneron Pharmaceuticals, Inc. 14,70011.4M $
66Carlsmed Inc 1,252,60011.3M $
67Biogen Inc 61,60011.3M $
68Keros Therapeutics Inc 759,1558.4M $
69Gilead Sciences Inc 59,6008.3M $
70Heron Therapeutics Inc 9,816,9407.9M $
71AVALO THERAPEUTICS INC 475,1657.1M $
72Tectonic Therapeutic Inc 226,6007M $
73Adicet Bio Inc 1,027,9447M $
74Compass Pathways plc 1,150,6466.4M $
75ALX Oncology Holdings Inc 2,866,2565.7M $
76Artivion Inc 151,0005.5M $
77InspireMD, Inc. 3,133,4055.1M $
78Revolution Medicines Inc 52,0005.1M $
79Protagonist Therapeutics Inc 42,1004.4M $
80Palisade Bio Inc 2,333,0004.1M $
81Alto Neuroscience Inc 167,5003.8M $
82Savara Inc 635,0003.5M $
83Cullinan Therapeutics Inc 243,0063.5M $
84PTC Therapeutics Inc 49,1003.3M $
85LifeStance Health Group Inc 500,0003.2M $
86JADE BIOSCIENCES INC 185,0112.6M $
87C4 Therapeutics Inc 856,3532.3M $
88Avita Medical Inc 544,8952M $
89KalVista Pharmaceuticals Inc 94,4001.9M $
90IMAGENEBIO INC 378,5561.9M $
91VISTAGEN THERAPEUTICS INC 3,060,0001.7M $
92AtaiBeckley Inc 347,0001.2M $
93TRAWS PHARMA INC 605,5311.1M $

Download this table: CSV, JSON

Sector breakdown

  • Health care 29.5 %
  • Unattributed 70.5 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • United States 94.9 %
  • Netherlands 2.6 %
  • France 1.3 %
  • Denmark 1.1 %
  • United Kingdom 0.2 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1United States893.7B $94.89 %
2Netherlands1100M $2.55 %
3France151.9M $1.32 %
4Denmark141.6M $1.06 %
5United Kingdom16.4M $0.16 %
Cite this page

Titelia. "Holdings of ORBIMED ADVISORS LLC". https://titelia.com/en/funds/US13F1055951